SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (10517)10/31/1997 4:06:00 PM
From: lavalamp  Read Replies (3) | Respond to of 32384
 
To the Thread,

does anyone know if Nov. 3 is still the date of the purchase of the joint venture or has it been delayed?



To: Andrew H who wrote (10517)10/31/1997 4:17:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
Andy, Diabetes is in the news. I expect several article to come out next week discussing diabetes treatments, including rexinoids such as Targretin (and of course LGND will be prominantly mentioned).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News